These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 32119846

  • 21. Excess androgen during puberty disrupts circadian organization in female rats.
    Sellix MT, Murphy ZC, Menaker M.
    Endocrinology; 2013 Apr; 154(4):1636-47. PubMed ID: 23417420
    [Abstract] [Full Text] [Related]

  • 22. Effects of BMAL1-SIRT1-positive cycle on estrogen synthesis in human ovarian granulosa cells: an implicative role of BMAL1 in PCOS.
    Zhang J, Liu J, Zhu K, Hong Y, Sun Y, Zhao X, Du Y, Chen ZJ.
    Endocrine; 2016 Aug; 53(2):574-84. PubMed ID: 27117143
    [Abstract] [Full Text] [Related]

  • 23. Polycystic ovary syndrome.
    Goudas VT, Dumesic DA.
    Endocrinol Metab Clin North Am; 1997 Dec; 26(4):893-912. PubMed ID: 9429864
    [Abstract] [Full Text] [Related]

  • 24. Thiazolidinediones for the therapeutic management of polycystic ovary syndrome : impact on metabolic and reproductive abnormalities.
    Elkind-Hirsch KE.
    Treat Endocrinol; 2006 Dec; 5(3):171-87. PubMed ID: 16677059
    [Abstract] [Full Text] [Related]

  • 25. Hyperandrogenism and Insulin Resistance, Not Changes in Body Weight, Mediate the Development of Endothelial Dysfunction in a Female Rat Model of Polycystic Ovary Syndrome (PCOS).
    Hurliman A, Keller Brown J, Maille N, Mandala M, Casson P, Osol G.
    Endocrinology; 2015 Nov; 156(11):4071-80. PubMed ID: 26322372
    [Abstract] [Full Text] [Related]

  • 26. Melatonin alleviates insulin resistance through the PI3K/AKT signaling pathway in ovary granulosa cells of polycystic ovary syndrome.
    Guo R, Zheng H, Li Q, Qiu X, Zhang J, Cheng Z.
    Reprod Biol; 2022 Mar; 22(1):100594. PubMed ID: 34953312
    [Abstract] [Full Text] [Related]

  • 27. Role of hyperinsulinemia in the pathogenesis of the polycystic ovary syndrome, and its clinical implications.
    Nestler JE.
    Semin Reprod Endocrinol; 1997 May; 15(2):111-22. PubMed ID: 9165656
    [Abstract] [Full Text] [Related]

  • 28. Polycystic ovary syndrome and insulin-resistant hyperinsulinemia.
    Rosenfield RL.
    J Am Acad Dermatol; 2001 Sep; 45(3 Suppl):S95-104. PubMed ID: 11511859
    [Abstract] [Full Text] [Related]

  • 29. The use of dehydroepiandrosterone-treated rats is not a good animal model for the study of metabolic abnormalities in polycystic ovary syndrome.
    Seow KM, Ting CH, Huang SW, Ho LT, Juan CC.
    Taiwan J Obstet Gynecol; 2018 Oct; 57(5):696-704. PubMed ID: 30342654
    [Abstract] [Full Text] [Related]

  • 30. Downregulation of core clock gene Bmal1 attenuates expression of progesterone and prostaglandin biosynthesis-related genes in rat luteinizing granulosa cells.
    Chen H, Zhao L, Kumazawa M, Yamauchi N, Shigeyoshi Y, Hashimoto S, Hattori MA.
    Am J Physiol Cell Physiol; 2013 Jun 15; 304(12):C1131-40. PubMed ID: 23596172
    [Abstract] [Full Text] [Related]

  • 31. Hyperinsulinism and its interaction with hyperandrogenism in polycystic ovary syndrome.
    Sozen I, Arici A.
    Obstet Gynecol Surv; 2000 May 15; 55(5):321-8. PubMed ID: 10804539
    [Abstract] [Full Text] [Related]

  • 32. Functional central rhythmicity and light entrainment, but not liver and muscle rhythmicity, are Clock independent.
    Kennaway DJ, Owens JA, Voultsios A, Varcoe TJ.
    Am J Physiol Regul Integr Comp Physiol; 2006 Oct 15; 291(4):R1172-80. PubMed ID: 16709646
    [Abstract] [Full Text] [Related]

  • 33. 17-hydroxyprogesterone responses to gonadotropin-releasing hormone disclose distinct phenotypes of functional ovarian hyperandrogenism and polycystic ovary syndrome.
    Pasquali R, Patton L, Pocognoli P, Cognigni GE, Gambineri A.
    J Clin Endocrinol Metab; 2007 Nov 15; 92(11):4208-17. PubMed ID: 17785360
    [Abstract] [Full Text] [Related]

  • 34. Association between circadian rhythm disruption and polycystic ovary syndrome.
    Wang F, Xie N, Wu Y, Zhang Q, Zhu Y, Dai M, Zhou J, Pan J, Tang M, Cheng Q, Shi B, Guo Q, Li X, Xie L, Wang B, Yang D, Weng Q, Guo L, Ye J, Pan M, Zhang S, Zhou H, Zhen C, Liu P, Ning K, Brackenridge L, Hardiman PJ, Qu F.
    Fertil Steril; 2021 Mar 15; 115(3):771-781. PubMed ID: 33358334
    [Abstract] [Full Text] [Related]

  • 35. Heterogenous origins of hyperandrogenism in the polycystic ovary syndrome in relation to body mass index and insulin resistance.
    Patlolla S, Vaikkakara S, Sachan A, Venkatanarasu A, Bachimanchi B, Bitla A, Settipalli S, Pathiputturu S, Sugali RN, Chiri S.
    Gynecol Endocrinol; 2018 Mar 15; 34(3):238-242. PubMed ID: 29068242
    [Abstract] [Full Text] [Related]

  • 36. Follicle luteinization in hyperandrogenic follicles of polycystic ovary syndrome patients undergoing gonadotropin therapy for in vitro fertilization.
    Foong SC, Abbott DH, Zschunke MA, Lesnick TG, Phy JL, Dumesic DA.
    J Clin Endocrinol Metab; 2006 Jun 15; 91(6):2327-33. PubMed ID: 16551732
    [Abstract] [Full Text] [Related]

  • 37. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models.
    Caldwell AS, Middleton LJ, Jimenez M, Desai R, McMahon AC, Allan CM, Handelsman DJ, Walters KA.
    Endocrinology; 2014 Aug 15; 155(8):3146-59. PubMed ID: 24877633
    [Abstract] [Full Text] [Related]

  • 38. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
    Hassa H, Tanir HM, Yildiz Z.
    Arch Gynecol Obstet; 2006 Jul 15; 274(4):227-32. PubMed ID: 16691383
    [Abstract] [Full Text] [Related]

  • 39. Metformin and sitagliptin combination therapy ameliorates polycystic ovary syndrome with insulin resistance through upregulation of lncRNA H19.
    Wang Q, Shang J, Zhang Y, Zhou W.
    Cell Cycle; 2019 Oct 15; 18(19):2538-2549. PubMed ID: 31405334
    [Abstract] [Full Text] [Related]

  • 40. Differential patterns in the periodicity and dynamics of clock gene expression in mouse liver and stomach.
    Mazzoccoli G, Francavilla M, Pazienza V, Benegiamo G, Piepoli A, Vinciguerra M, Giuliani F, Yamamoto T, Takumi T.
    Chronobiol Int; 2012 Dec 15; 29(10):1300-11. PubMed ID: 23131081
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.